Cargando…
TMT-Based Proteomics Analysis of the Intervention Effect of Orlistat on Polycystic Ovary Syndrome Rats Induced by Letrozole Combined with a High-Fat Diet
[Image: see text] Polycystic ovary syndrome (PCOS) is a complex gynecological endocrine and metabolic disease. Orlistat as a lipase inhibitor may improve the pathological characteristics of PCOS and is the sole antiobesity agent available in various countries. In this study, the PCOS rat models were...
Autores principales: | Yang, Jianmei, Wang, Enli, Chen, Wenbin, Xu, Baihui, Chen, Chen, Zhang, Guimin, Yao, Jingchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357523/ https://www.ncbi.nlm.nih.gov/pubmed/37483206 http://dx.doi.org/10.1021/acsomega.3c00578 |
Ejemplares similares
-
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
por: Yang, Jianmei, et al.
Publicado: (2023) -
Effect of High-Fat Diet on the Intestinal Flora in Letrozole-Induced Polycystic Ovary Syndrome Rats
por: Zheng, Yan-Hua, et al.
Publicado: (2021) -
A Rat Model of Polycystic Ovary Syndrome with Insulin Resistance Induced by Letrozole Combined with High Fat Diet
por: Wang, Ming-Xing, et al.
Publicado: (2020) -
Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome
por: Guo, Zaixin, et al.
Publicado: (2023) -
Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome
por: Hajishafiha, Masomeh, et al.
Publicado: (2013)